Claims that “supercharged biotech rice” yields massively more grain debunked
By Jonathan Matthews and Claire Robinson,
GMWatch
| 08. 14. 2022
Photo by Polina Rytova on Unsplash
Science Magazine recently published a paper in which Chinese scientists reported massive yield gains in rice, thanks to genetic engineering. The journal also promoted the research in a news piece that featured other scientists expressing their amazement at the yield gains achieved. The article suggested the same “genetic tweak” to a single gene could also turbocharge the yields of wheat and other crops.
News of this apparent breakthrough in how to boost global food supplies spread like wildfire on social media and triggered press coverage too. But now a young scientist studying plant breeding has debunked the paper’s claims and dismissed as bogus the whole idea that scientists can “solve” yield through single genes.
“That’s a big number. Amazing”
The “world's leading outlet for cutting-edge research”, as Science styles itself, made sure this GM rice study by a 13-strong team led by crop physiologist Wenbin Zhou of the Chinese Academy of Agricultural Sciences, commanded maximum attention.
In both the Abstract and the longer Structured Abstract that Science published, the yield increases cited for the...
Related Articles
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...
By Jessica Hamzelou, MIT Technology Review | 11.07.2025
This week, we heard that Tom Brady had his dog cloned. The former quarterback revealed that his Junie is actually a clone of Lua, a pit bull mix that died in 2023.
Brady’s announcement follows those of celebrities like Paris...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...